T. Rowe Price ETFs See Massive Volume Spikes in Balanced Market Session

Share

Macro Summary

Total ETF market volume registered $288.47 billion, a figure perfectly aligned with recent trends at 101% of the 30-day average daily volume. The session presented a mixed picture of activity, with Equity and Non-Traditional asset classes showing slightly elevated turnover. In contrast, trading was notably subdued across Fixed Income, Commodities, and Digital Assets, indicating a focused and selective approach from market participants rather than broad-based conviction.

Asset Class Volume 30D Avg. % of 30D Avg.
Equity $196.84B $189.82B 104%
Fixed Income $25.49B $27.92B 91%
Commodities $5.43B $7.20B 75%
Digital Asset $3.12B $4.65B 67%
Currencies $104.3M $118.7M 88%
Alternatives $924.0M $1.04B 89%
Non-Traditional $56.39B $54.03B 104%
Multi-Asset $189.5M $268.5M 71%
Total $288.47B $285.04B 101%

Equity

Equity ETFs traded $196.84 billion, representing a modest 104% of their recent average. The session was defined by extraordinary activity in a handful of specific funds, particularly from T. Rowe Price. The T. Rowe Price Growth ETF (TGRT) traded over 5,900% of its average, while its U.S. Equity Research ETF (TSPA) and Small-Mid Cap ETF (TMSL) also saw volumes explode by 1,317% and 999%, respectively. At the category level, Asia-Pacific Emerging Market funds were a standout at 1,195% of average volume, largely driven by a 1,444% surge in the iShares MSCI Emerging Markets Asia ETF (EEMA). Hedged and Disruptive Tech strategies also saw significant interest.

High-Volume Categories

Category Activity vs ADV $ Volume 1-Day Return
Equity: Region – Asia-Pacific Emerging 1,195% $168.6M -5.42%
Equity: Specialty – Hedged 633% $332.0M -0.95%
Equity: Thematic – Disruptive Tech 200% $7.93B -2.93%
Equity: Thematic – Health Innovation 181% $186.7M +1.04%
Equity: Thematic – Midstream & MLPs 147% $202.4M +1.25%

High-Activity Ticker Outliers

Ticker Name Activity vs ADV $ Volume 1D Return
TGRT T. Rowe Price Growth ETF 5,921% $220.6M -2.10%
EEMA iShares MSCI Emerging Markets Asia ETF 1,444% $166.5M -5.20%
TSPA T. Rowe Price U.S. Equity Research ETF 1,317% $292.1M -1.59%
TMSL T. Rowe Price Small-Mid Cap ETF 999% $116.4M -2.26%
IXP iShares Global Comm Services ETF 881% $24.9M -0.38%
CGCV Capital Group Conservative Equity ETF 877% $67.1M -0.08%
PSP Invesco Global Listed Private Equity ETF 750% $20.8M -2.62%
TCAF T. Rowe Price Capital Appreciation Equity ETF 569% $149.5M -0.79%
SFTY Horizon Managed Risk ETF 543% $20.7M -1.35%
MFSV MFS Active Value ETF 531% $18.0M -0.39%

Fixed Income

Fixed Income ETFs saw a quiet day, with total volume of $25.49 billion coming in at just 91% of the 30-day average. Despite the overall lull, Securitized debt was a pocket of activity, trading 134% of its typical volume. Similar to the equity space, a T. Rowe Price fund was the standout outlier; the T. Rowe Price QM U.S. Bond ETF (TAGG) saw an exceptional 2,539% of its average daily volume. Other notable activity occurred in mortgage-backed securities, with the JPMorgan Mortgage-Backed Securities ETF (JMTG) trading at 735% of its norm.

High-Volume Categories

Category Activity vs ADV $ Volume 1-Day Return
Fixed Income: Taxable – Securitized 134% $603.2M +0.04%

High-Activity Ticker Outliers

Ticker Name Activity vs ADV $ Volume 1D Return
TAGG T. Rowe Price QM U.S. Bond ETF 2,539% $116.3M +0.06%
JMTG JPMorgan Mortgage-Backed Securities ETF 735% $285.4M -0.19%
JSCP JPMorgan Short Duration Core Plus ETF 732% $70.9M +0.09%
SYFI AB Short Duration High Yield ETF 473% $20.3M -0.03%
TOTL State Street DoubleLine Total Return Tactical ETF 397% $63.3M -0.17%
CEMB iShares J.P. Morgan EM Corporate Bond ETF 344% $10.3M -0.23%
FLUD Franklin Ultra Short Bond ETF 337% $21.4M +0.06%
IBTL iShares iBonds Dec 2031 Term Treasury ETF 309% $9.9M +0.17%
IBTM iShares iBonds Dec 2032 Term Treasury ETF 293% $7.9M +0.16%
FLDR Fidelity Low Duration Bond Factor ETF 272% $49.1M +0.05%

Commodities

Commodities-focused ETFs experienced a subdued session, with total volume reaching only $5.43 billion, or 75% of the 30-day average. There were no broad category-level catalysts driving activity. Only two funds saw volume notably above their recent norms: the ProShares K-1 Free Crude Oil ETF of Benef Interest (OILK) at 205% of its average, and the abrdn Physical Palladium Shares ETF (PALL) at 152%.

High-Volume Categories

No items met the inclusion criteria for this session.

High-Activity Ticker Outliers

Ticker Name Activity vs ADV $ Volume 1D Return
OILK ProShares K-1 Free Crude Oil ETF of Benef Interest 205% $23.6M -0.56%
PALL abrdn Physical Palladium Shares ETF 152% $30.4M -2.20%

Digital Asset

Activity in Digital Asset ETFs was significantly muted, with turnover of just $3.12 billion, representing only 67% of the 30-day average daily volume. No specific categories or individual tickers registered trading activity above their recent norms, indicating a quiet session for the asset class.

High-Volume Categories

No items met the inclusion criteria for this session.

High-Activity Ticker Outliers

No items met the inclusion criteria for this session.

Currencies

Currency ETFs saw a quiet trading day, with total volume of $104.3 million equating to 88% of the 30-day average. No individual funds or currency categories experienced unusual trading activity, marking a session of below-average interest for the space.

High-Volume Categories

No items met the inclusion criteria for this session.

High-Activity Ticker Outliers

No items met the inclusion criteria for this session.

Alternatives

Alternatives ETFs posted a quiet session with total volume of $924.0 million, or 89% of their 30-day average. Trading was broadly in line with recent trends, and no specific categories or individual tickers stood out for having unusually high turnover.

High-Volume Categories

No items met the inclusion criteria for this session.

High-Activity Ticker Outliers

No items met the inclusion criteria for this session.

Non-Traditional

Non-Traditional ETFs traded $56.39 billion, a slightly elevated 104% of their 30-day average. The primary driver was the Buffer – Equity category, which saw turnover at 190% of its norm. This was led by the FT Vest U.S. Equity Buffer ETF – June (FJUN), which experienced a massive 2,157% surge in volume. Leveraged products also saw heavy trading, notably the Direxion Daily MSCI South Korea Bull 3X ETF (KORU), which traded nearly $1.5 billion.

High-Volume Categories

Category Activity vs ADV $ Volume 1-Day Return
Non-Traditional: Buffer – Equity 190% $791.9M -0.54%

High-Activity Ticker Outliers

Ticker Name Activity vs ADV $ Volume 1D Return
FJUN FT Vest U.S. Equity Buffer ETF – June 2,157% $56.7M -0.81%
FMAY FT Vest U.S. Equity Buffer Fund – May 842% $44.7M -0.79%
GMAY FT Vest U.S. Equity Moderate Buffer ETF – May 423% $33.9M -0.74%
WDCX Tradr 2X Long WDC Daily ETF 207% $110.7M -14.63%
KORU Direxion Daily MSCI South Korea Bull 3X ETF 202% $1.48B -35.76%
ROCQ JPMorgan Nasdaq Equity Premium Yield ETF 187% $20.4M -2.34%
GSEP FT Vest U.S. Equity Moderate Buffer ETF – September 183% $8.2M -0.43%
SDVD FT Vest SMID Rising Dividend Achievers Target Income ETF 166% $5.2M -0.22%
TDVI FT Vest Technology Dividend Target Income ETF 165% $4.8M -2.42%
CHPY YieldMax Semiconductor Portfolio Option Income ETF 159% $95.3M -6.95%

Multi-Asset

Multi-Asset ETFs recorded a very quiet session, with total volume of just $189.5 million, representing 71% of the 30-day average. Activity was subdued across the category, with no individual funds showing notable deviations from their typical trading volumes.

High-Volume Categories

No items met the inclusion criteria for this session.

High-Activity Ticker Outliers

No items met the inclusion criteria for this session.

Single-Stock Volume

Single-stock activity was highlighted by several extreme outliers. Atlantic International Corp (ATLN) saw an astronomical volume spike of 170,506% above its 30-day average on turnover of $577.0 million. Ligand Pharmaceuticals Incorporated (LGND) also experienced a massive surge, trading 1,171% of its norm. Other heavily traded names included Apogee Therapeutics, Inc. (APGE) and Accenture Plc (ACN), which saw dollar volumes of $1.27 billion and $2.38 billion, respectively. Among the high-volume stocks, several are tracked by ETFs, including American Airlines Group Inc. (AAL) and Novo Nordisk (NVO).

High-Activity Single Stocks (vs 30-Day ADV)

Stock Name Activity vs ADV $ Volume 1D Return ETFs Tracking
ATLN Atlantic International Corp 170,506% $577.0M +221.74%
LGND Ligand Pharmaceuticals Incorporated 1,171% $633.2M +6.37%
APGE Apogee Therapeutics, Inc. 371% $1.27B +0.23%
PRIM Primoris Services Corporation 361% $815.6M -21.54%
ARGX argenx SE Sponsored ADR 233% $617.8M +0.43%
ACN Accenture Plc Class A 212% $2.38B +1.54%
INFQ Infleqtion, Inc. 211% $647.1M +12.17% 1
AAL American Airlines Group Inc. 203% $2.62B +0.52% 1
BLK BlackRock, Inc. 190% $1.29B -3.40%
AZO AutoZone, Inc. 189% $2.29B +3.25%
HL Hecla Mining Company 170% $535.0M -5.51%
NVO Novo Nordisk A/S Sponsored ADR Class B 169% $910.6M +3.30% 2
ENTG Entegris, Inc. 165% $720.9M -6.48%
RCL Royal Caribbean Group 165% $1.20B -0.20%
VRT Vertiv Holdings Co. Class A 161% $2.99B -10.79% 1

Disclaimer: This AI-assisted commentary is for informational purposes only. The “High-Volume Categories” table includes categories with over $100M in volume and activity at least 125% of their 30-day average, limited to the top 5 by activity percentage. The “High-Activity Ticker Outliers” table shows the top 10 ETFs from each asset class, sorted by the highest trading activity versus their 30-day average. All reported ETFs have AUM over $250M and an ADV greater than $2.5M.

Disclosures: This material is for informational purposes only and should not be considered investment advice. All investments, including ETFs, involve risk, including the possible loss of principal. Investors should consider their investment objectives, risks, charges, and expenses carefully before investing.

This analysis was developed by the team at ETF Action. We leverage advanced AI tools to assist in the drafting and refinement of our content, based on our expert prompts, direction, and final review.